Notification

🚨 Trading Holiday 🚨

The NSE and BSE will remain closed for trading and settlement on Monday, April 14, 2025, on account of Dr. B. R. Ambedkar Jayanti.

Open a Free Demat Account

Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.

Trade Now, Pay Later with up to 4x

Never miss a good trading opportunity due to low funds with our MTF feature.

Track Market Movers Instantly

Stay updated with real-time data. Get insights at your fingertips.

NSE BSE

Trade Nowopens in a new tab

Seshasayee Paper & Boards Share Price

₹ 267.05 3.39 (1.28%)

Apr 15 2025 03:30 PM Paper NSE: SESHAPAPER

Seshasayee Paper & Boards Share Price Update

As of the latest trading session, Seshasayee Paper & Boards share price is currently at 267.05, which is up by 3.39 from its previous closing. Today, the stock has fluctuated between 263.60 and 269.45. Over the past year, Seshasayee Paper & Boards has achieved a return of -18.09 %. In the last month alone, the return has been -1.86 %. Read More...

Seshasayee Paper & Boards Performance

Day Range

Low263.60 High269.45

267.05

52 Week Range

Low 256.25 High 373.45

267.05

Seshasayee Paper & Boards Share Price

3066

502450

SESHAPAPER

Compare to down-arrow

View

Display

Studies

No Data Available

Open Price

264.00 Prev. Close

263.65 Volume (Shares)

13947.00

Total traded value

37.24 Upper Circuit

316.35 Lower Circuit

210.95

Note: The current prices & values are delayed, Loginopens in a new tab to your account for live updates.

Seshasayee Paper & Boards Fundamentals

(Standalone)

Market Cap (Cr)	1684.23
PE Ratio (TTM)	12.52
Book Value / Share	299.47
Beta	0.68

ROE	15.20%
EPS (TTM)	20.94
Dividend Yield	1.82%
Net Profit Qtr (Cr)	15.81

Seshasayee Paper & Boards Financials

Key Results
Key Ratios
Balance sheet
Cash Flow
Competition

Revenue

Net income

Particulars	DEC 2024 (Values in Cr)
Revenue	431.27
Operating Expense	436.68
Net Profit	15.81
Net Profit Margin (%)	3.66
Earnings Per Share (EPS)	2.63
EBITDA	28.17
Effective Tax Rate (%)	-4.56

Particulars	SEP 2024 (Values in Cr)
Revenue	398.40
Operating Expense	380.38
Net Profit	24.78
Net Profit Margin (%)	6.21
Earnings Per Share (EPS)	4.11
EBITDA	46.04
Effective Tax Rate (%)	25.63

Particulars	JUN 2024 (Values in Cr)
Revenue	422.16
Operating Expense	386.85
Net Profit	38.34
Net Profit Margin (%)	9.08
Earnings Per Share (EPS)	6.37
EBITDA	63.92
Effective Tax Rate (%)	25.48

Particulars	MAR 2024 (Values in Cr)
Revenue	539.36
Operating Expense	482.81
Net Profit	53.16
Net Profit Margin (%)	9.85
Earnings Per Share (EPS)	8.83
EBITDA	81.10
Effective Tax Rate (%)	23.91

Particulars	DEC 2023 (Values in Cr)
Revenue	473.41
Operating Expense	397.04
Net Profit	65.73
Net Profit Margin (%)	13.88
Earnings Per Share (EPS)	10.92
EBITDA	98.97
Effective Tax Rate (%)	25.05

Particulars	MAR 2024 (Values in Cr)
Revenue	1801.56
Operating Expense	1507.64
Net Profit	259.37
Net Profit Margin (%)	14.39
Earnings Per Share (EPS)	43.06
EBITDA	391.34
Effective Tax Rate (%)	24.90

Particulars	MAR 2023 (Values in Cr)
Revenue	2082.53
Operating Expense	1596.91
Net Profit	386.54
Net Profit Margin (%)	18.56
Earnings Per Share (EPS)	64.18
EBITDA	564.58
Effective Tax Rate (%)	25.10

Particulars	MAR 2022 (Values in Cr)
Revenue	1354.93
Operating Expense	1233.04
Net Profit	103.10
Net Profit Margin (%)	7.60
Earnings Per Share (EPS)	17.12
EBITDA	182.24
Effective Tax Rate (%)	25.58

Particulars	MAR 2021 (Values in Cr)
Revenue	781.79
Operating Expense	714.75
Net Profit	100.27
Net Profit Margin (%)	12.82
Earnings Per Share (EPS)	16.65
EBITDA	126.87
Effective Tax Rate (%)	-16.10

Particulars	MAR 2020 (Values in Cr)
Revenue	1183.98
Operating Expense	959.03
Net Profit	173.46
Net Profit Margin (%)	14.65
Earnings Per Share (EPS)	28.80
EBITDA	289.57
Effective Tax Rate (%)	29.96

Particulars	MAR 2024 (Values in Cr)
Book Value / Share	319.48
ROE %	15.27
ROCE %	19.70
Total Debt to Total Equity	0.01
EBITDA Margin	22.36

Particulars	MAR 2023 (Values in Cr)
Book Value / Share	273.64
ROE %	27.39
ROCE %	35.63
Total Debt to Total Equity	0.00
EBITDA Margin	27.56

Particulars	MAR 2022 (Values in Cr)
Book Value / Share	210.50
ROE %	9.18
ROCE %	11.98
Total Debt to Total Equity	0.00
EBITDA Margin	13.97

Particulars	MAR 2021 (Values in Cr)
Book Value / Share	191.80
ROE %	9.84
ROCE %	8.47
Total Debt to Total Equity	0.01
EBITDA Margin	17.01

Particulars	MAR 2020 (Values in Cr)
Book Value / Share	171.29
ROE %	18.99
ROCE %	25.06
Total Debt to Total Equity	0.06
EBITDA Margin	25.15

Particulars	MAR 2024 (Values in Cr)
Book Value / Share	307.22
ROE %	15.20
ROCE %	19.80
Total Debt to Total Equity	0.01
EBITDA Margin	21.72

Particulars	MAR 2023 (Values in Cr)
Book Value / Share	263.82
ROE %	27.79
ROCE %	36.33
Total Debt to Total Equity	0.00
EBITDA Margin	27.11

Particulars	MAR 2022 (Values in Cr)
Book Value / Share	202.25
ROE %	8.94
ROCE %	11.85
Total Debt to Total Equity	0.01
EBITDA Margin	13.45

Particulars	MAR 2021 (Values in Cr)
Book Value / Share	184.97
ROE %	9.61
ROCE %	8.20
Total Debt to Total Equity	0.01
EBITDA Margin	16.23

Particulars	MAR 2020 (Values in Cr)
Book Value / Share	165.76
ROE %	18.71
ROCE %	24.97
Total Debt to Total Equity	0.06
EBITDA Margin	24.46

Particulars	MAR 2024 (Values in Cr)
Cash & Short Term Investments	608.46
Total Assets	2391.41
Total Liabilities	2391.41
Total Equity	1911.31
Share Outstanding	63068140
Price to Book Ratio	0.96
Return on Assets (%)	11.32
Return on Capital (%)	14.01

Particulars	MAR 2023 (Values in Cr)
Cash & Short Term Investments	497.26
Total Assets	2078.83
Total Liabilities	2078.83
Total Equity	1635.36
Share Outstanding	63068140
Price to Book Ratio	0.90
Return on Assets (%)	19.04
Return on Capital (%)	24.2

Particulars	MAR 2022 (Values in Cr)
Cash & Short Term Investments	330.55
Total Assets	1659.67
Total Liabilities	1659.67
Total Equity	1255.26
Share Outstanding	63068140
Price to Book Ratio	0.86
Return on Assets (%)	6.62
Return on Capital (%)	8.74

Particulars	MAR 2021 (Values in Cr)
Cash & Short Term Investments	206.96
Total Assets	1517.51
Total Liabilities	1517.51
Total Equity	1142.73
Share Outstanding	63068140
Price to Book Ratio	0.87
Return on Assets (%)	7.00
Return on Capital (%)	9.28

Particulars	MAR 2020 (Values in Cr)
Cash & Short Term Investments	326.35
Total Assets	1448.07
Total Liabilities	1448.07
Total Equity	1019.25
Share Outstanding	63068140
Price to Book Ratio	0.63
Return on Assets (%)	12.54
Return on Capital (%)	17.7

Particulars	MAR 2024 (Values in Cr)
Cash & Short Term Investments	607.10
Total Assets	2317.40
Total Liabilities	2317.40
Total Equity	1837.53
Share Outstanding	63068140
Price to Book Ratio	0.96
Return on Assets (%)	11.19
Return on Capital (%)	13.96

Particulars	MAR 2023 (Values in Cr)
Cash & Short Term Investments	495.95
Total Assets	2019.54
Total Liabilities	2019.54
Total Equity	1576.29
Share Outstanding	63068140
Price to Book Ratio	0.90
Return on Assets (%)	19.14
Return on Capital (%)	24.52

Particulars	MAR 2022 (Values in Cr)
Cash & Short Term Investments	329.34
Total Assets	1609.79
Total Liabilities	1609.79
Total Equity	1205.60
Share Outstanding	63068140
Price to Book Ratio	0.86
Return on Assets (%)	6.40
Return on Capital (%)	8.52

Particulars	MAR 2021 (Values in Cr)
Cash & Short Term Investments	205.80
Total Assets	1476.16
Total Liabilities	1476.16
Total Equity	1101.60
Share Outstanding	63068140
Price to Book Ratio	0.87
Return on Assets (%)	6.79
Return on Capital (%)	9.07

Particulars	MAR 2020 (Values in Cr)
Cash & Short Term Investments	325.26
Total Assets	1414.55
Total Liabilities	1414.55
Total Equity	985.96
Share Outstanding	63068140
Price to Book Ratio	0.63
Return on Assets (%)	12.26
Return on Capital (%)	17.48

Particulars	MAR 2024 (Values in Cr)
Net Income	343.96
Cash from Operations	297.84
Cash from Investing	-225.22
Cash from Financing	-18.88
Net change in Cash	-41.93
Free Cash Flow	337.67

Particulars	MAR 2023 (Values in Cr)
Net Income	514.94
Cash from Operations	457.70
Cash from Investing	-371.81
Cash from Financing	-22.35
Net change in Cash	-65.61
Free Cash Flow	489.68

Particulars	MAR 2022 (Values in Cr)
Net Income	137.50
Cash from Operations	304.50
Cash from Investing	-250.96
Cash from Financing	-22.04
Net change in Cash	2.57
Free Cash Flow	408.78

Particulars	MAR 2021 (Values in Cr)
Net Income	85.44
Cash from Operations	10.06
Cash from Investing	-53.55
Cash from Financing	-30.56
Net change in Cash	-91.20
Free Cash Flow	112.24

Particulars	MAR 2020 (Values in Cr)
Net Income	247.34
Cash from Operations	210.87
Cash from Investing	-26.12
Cash from Financing	-124.30
Net change in Cash	14.85
Free Cash Flow	256.76

Particulars	MAR 2024 (Values in Cr)
Net Income	345.40
Cash from Operations	297.82
Cash from Investing	-225.23
Cash from Financing	-18.88
Net change in Cash	-41.91
Free Cash Flow	337.65

Particulars	MAR 2023 (Values in Cr)
Net Income	516.14
Cash from Operations	457.59
Cash from Investing	-371.76
Cash from Financing	-22.35
Net change in Cash	-65.65
Free Cash Flow	489.54

Particulars	MAR 2022 (Values in Cr)
Net Income	138.54
Cash from Operations	304.43
Cash from Investing	-250.96
Cash from Financing	-22.04
Net change in Cash	2.57
Free Cash Flow	408.70

Particulars	MAR 2021 (Values in Cr)
Net Income	86.36
Cash from Operations	10.00
Cash from Investing	-53.34
Cash from Financing	-30.56
Net change in Cash	-91.01
Free Cash Flow	112.17

Particulars	MAR 2020 (Values in Cr)
Net Income	247.68
Cash from Operations	210.51
Cash from Investing	-25.96
Cash from Financing	-124.30
Net change in Cash	14.69
Free Cash Flow	256.18

Company Name	Price	P/E	P/B	Market Cap	52 Week Low/High
ADITYA BIRLA REAL EST LTD	1787.50	143.81	4.92	19965.60	1638.00 / 3141.95
WEST COAST PAPER MILLS LT	434.75	7.42	0.83	2871.52	382.15 / 753.80
PAKKA LIMITED	171.85	18.22	1.70	772.43	155.00 / 363.00
JK PAPER LIMITED	320.90	8.92	1.03	5436.12	276.00 / 639.15

Company Name	Price	P/E	P/B	Market Cap	52 Week Low/High
ANDHRA PAPER LIMITED	71.14	11.84	0.72	1414.62	65.71 / 127.60
BALLARPUR INDUSTRIES LTD.	0.89	0.00	0.16	115.12	0.00 / 0.00
ADITYA BIRLA REAL EST LTD	1787.50	90.69	4.45	19965.60	1638.00 / 3141.95
ORIENT PAPER AND INDS LTD	22.34	0.00	0.27	474.02	20.81 / 62.20

Technicals

EMA & SMA
Resistance and Support
Price Change Analysis

Bullish Moving Averages -

Bearish Moving Averages -

5 Days 263.10
26 Days 270.20
10 Days 264.50
50 Days 277.60
12 Days 265.20
100 Days 289.50
20 Days 268.10
200 Days 303.00

262.93
PIVOT

First Resistance	267.22
Second Resistance	270.78
Third Resistance	275.07

First Support	259.37
Second Support	255.08
Third Support	251.52

RSI	44.49
MACD	-5.00
Commodity Channel Index (CCI)	-74.17

ADX	15.77
Williams % R	-70.98

Seshasayee Paper & Boards Future

Future: Price

25 May

0 100 200 300 400 500 600

Discount/Premium

25 May

0 1 2 3 4 5 6 7

Active Calls

25 May

0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul

0 500 1000 1500 2000 2500

Stock Holding

View Live Stock Screeners

Holding

Public

44.05 Promoter Holdings

42.81 FII

13.05 DII

0.08 Promoter Shares(Pledge Percentage)

0.0

Name	Category	Shares	Shares%
The Tamil Nadu Industrial Investment Corpn Ltd	Public Shareholding	9000000.0	14.27
Ponni Sugars (erode) Limited	Shareholding of Promoter and Promoter Group	8840905.0	14.02
Synergy Investments Pte Ltd	Shareholding of Promoter and Promoter Group	7738475.0	12.27
Time Square Investments Private Ltd	Shareholding of Promoter and Promoter Group	6387502.0	10.13
Atyant Capital India Fund I	Public Shareholding	3383140.0	5.36
Dhanashree Investments Private Ltd	Shareholding of Promoter and Promoter Group	2963307.0	4.7
Ayyalu Lakshminarasimha Somayaji	Public Shareholding	2840905.0	4.5
Gothic Corporation	Public Shareholding	1143879.0	1.81
Vanderbilt University - Atyant Capital Management Ltd	Public Shareholding	1133634.0	1.8
Pushpa Devi Saraogi	Public Shareholding	1124995.0	1.78
Usha Devi Saraogi	Public Shareholding	1124950.0	1.78
Ultra Investments And Leasing Company Private Ltd	Shareholding of Promoter and Promoter Group	926480.0	1.47
Gopalaratnam N	Shareholding of Promoter and Promoter Group	78155.0	0.12
High Energy Batteries (india) Limited	Shareholding of Promoter and Promoter Group	51645.0	0.08
Spb Projects And Consultancy Ltd	Shareholding of Promoter and Promoter Group	11360.0	0.02
Kasi Viswanathan K S	Shareholding of Promoter and Promoter Group	2910.0	0.0

Seshasayee Paper & Boards

Ex-Date	Dividend Amt.	Dividend Type	Record Date	Instrument Type
2023-06-07	6.0	Final	2023-06-08	Equity shares	2022-07-12	2.5	Final	2022-07-14	Equity shares	2021-07-13	2.5	Final	2021-07-15	Equity shares	2020-07-28	3.5	Final	2020-07-30	Equity shares	2020-07-28	0.5	Special	2020-07-30	Equity shares	2019-07-16	20.0	Final	2019-07-18	Equity shares	2018-07-10	15.0	Final	2018-07-12	Equity shares	2017-07-18	10.0	Final	2017-07-20	Equity shares	2016-07-14	5.0	Final	2016-07-16	Equity shares	2015-07-21	4.0	Final	2015-07-23	Equity shares	2014-07-15	4.0	Final	2014-07-17	Equity shares	2013-07-17	4.0	Final	2013-07-19	Equity shares	2012-07-18	5.0	Final	2012-07-20	Equity shares	2011-07-12	5.0	Final	2011-07-14	Equity shares	2010-07-13	3.5	Final	2010-07-15	Equity shares	2010-07-13	2.5	Special	2010-07-15	Equity shares	2009-07-14	3.5	Final	2009-07-16	Equity shares	2008-07-15	4.0	Final	2008-07-17	Equity shares	2007-07-16	3.5	Final	2007-07-18	Equity shares	2005-07-12	0.0	Final	2005-07-14	Equity shares

Learn More About Stocks

Dr Reddy’s Denies Workforce Reduction Claims Amid Cost-Cut Rumours

Dr Reddy’s Laboratories rejects claims of reducing workforce costs by 25%, asserting no such plans or internal directives.

15 Apr, 2025 | 3 Min. read

Glenmark, Sun Pharma, Zydus Recall Drugs in US over Compliance Issues

Glenmark, Sun Pharma, and Zydus recall multiple drug batches in the US following manufacturing deviations and contamination concerns as per USFDA enforcement reports.

15 Apr, 2025 | 3 Min. read

HAL Denies Selecting PwC for R&D Benchmarking Amid Ongoing Bids

HAL clarifies no consultancy firm has been finalised for R&D benchmarking amid social media buzz about PwC. Selection process still ongoing via GeM portal.

15 Apr, 2025 | 3 Min. read

Aurobindo Pharma Gets USFDA Nod for Generic Xarelto 2.5mg Tablets

Aurobindo Pharma receives USFDA approval to launch generic Xarelto 2.5mg in Q1 FY26, targeting $447 million US market; higher strengths also gain tentative nod.

15 Apr, 2025 | 3 Min. read

IndiGo Becomes World’s Most Valuable Airline With $23.4 Billion Market Cap

IndiGo surpasses global peers to become the most valuable airline by market cap at $23.4 billion, pushing InterGlobe Aviation share price to record highs in 2025.

11 Apr, 2025 | 3 Min. read

SRF Ltd. Commissions New Agrochemical Unit in Dahej Worth Rs.239 Crore

SRF Ltd. starts new agrochemical facility in Dahej, Gujarat with Rs.239 crore investment. Phase 1 operational, full commissioning set for April 2025.

11 Apr, 2025 | 3 Min. read

Tata Motors’ JLR India Achieves Record Sales in FY25 at 6,183 Units

JLR India posts record-breaking FY25 retail sales of 6,183 units, up 40%. Defender leads growth, boosting Tata Motors share price sentiment.

11 Apr, 2025 | 4 Min. read

Biocon Gets USFDA Approval for Jobevne, Expands Oncology Portfolio

Biocon Biologics receives USFDA nod for cancer drug Jobevne, a bevacizumab biosimilar. Oncology portfolio in US grows, boosting Biocon Ltd. share price outlook.

11 Apr, 2025 | 3 Min. read